NCT03006081View on ClinicalTrials.gov

The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Diabetic Retinopathy

PHASE2UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2018

Conditions
Diabetic Retinopathy
Interventions
DRUG

Intravitreal Aflibercept injection

Six number of injections at baseline, 1M, 2M, 3M, 4M, and 5M

Trial Locations (1)

05505

RECRUITING

Asan medical center, Olympicro 43 Gil 88, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT03006081 - The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Diabetic Retinopathy | Biotech Hunter | Biotech Hunter